Software - Infrastructure
Compare Stocks
4 / 10Stock Comparison
AVPT vs VRNS vs CYBR vs QLYS
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Infrastructure
Software - Infrastructure
AVPT vs VRNS vs CYBR vs QLYS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Infrastructure | Software - Infrastructure | Software - Infrastructure |
| Market Cap | $2.23B | $3.37B | $20.64B | $3.34B |
| Revenue (TTM) | $444M | $660M | $1.36B | $685M |
| Net Income (TTM) | $47M | $-137M | $-147M | $201M |
| Gross Margin | 73.7% | 78.1% | 74.3% | 83.1% |
| Operating Margin | 9.6% | -21.9% | -7.7% | 33.7% |
| Forward P/E | 27.7x | 242.2x | 81.9x | 12.9x |
| Total Debt | $10M | $572M | $1.22B | $97M |
| Cash & Equiv. | $481M | $202M | $623M | $250M |
AVPT vs VRNS vs CYBR vs QLYS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AvePoint, Inc. (AVPT) | 100 | 105.4 | +5.4% |
| Varonis Systems, In… (VRNS) | 100 | 102.0 | +2.0% |
| CyberArk Software L… (CYBR) | 100 | 415.1 | +315.1% |
| Qualys, Inc. (QLYS) | 100 | 82.3 | -17.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVPT vs VRNS vs CYBR vs QLYS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AVPT is the clearest fit if your priority is growth exposure.
- Rev growth 26.9%, EPS growth 193.8%, 3Y rev CAGR 21.8%
VRNS lags the leaders in this set but could rank higher in a more targeted comparison.
CYBR is the #2 pick in this set and the best alternative if long-term compounding and defensive is your priority.
- 9.0% 10Y total return vs VRNS's 317.5%
- Beta 0.92, current ratio 2.00x
- 36.0% revenue growth vs QLYS's 10.1%
- +13.3% vs AVPT's -40.0%
QLYS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- beta 0.53
- Lower volatility, beta 0.53, Low D/E 17.3%, current ratio 1.41x
- Lower P/E (12.9x vs 81.9x)
- 29.4% margin vs VRNS's -20.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.0% revenue growth vs QLYS's 10.1% | |
| Value | Lower P/E (12.9x vs 81.9x) | |
| Quality / Margins | 29.4% margin vs VRNS's -20.7% | |
| Stability / Safety | Beta 0.53 vs AVPT's 1.06 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +13.3% vs AVPT's -40.0% | |
| Efficiency (ROA) | 19.1% ROA vs VRNS's -8.2%, ROIC 47.5% vs -11.0% |
AVPT vs VRNS vs CYBR vs QLYS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AVPT vs VRNS vs CYBR vs QLYS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
QLYS leads in 2 of 6 categories
AVPT leads 1 • CYBR leads 1 • VRNS leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
QLYS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CYBR is the larger business by revenue, generating $1.4B annually — 3.1x AVPT's $444M. QLYS is the more profitable business, keeping 29.4% of every revenue dollar as net income compared to VRNS's -20.7%. On growth, VRNS holds the edge at +26.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $444M | $660M | $1.4B | $685M |
| EBITDAEarnings before interest/tax | $47M | -$135M | $23M | $241M |
| Net IncomeAfter-tax profit | $47M | -$137M | -$147M | $201M |
| Free Cash FlowCash after capex | $105M | $120M | $259M | $290M |
| Gross MarginGross profit ÷ Revenue | +73.7% | +78.1% | +74.3% | +83.1% |
| Operating MarginEBIT ÷ Revenue | +9.6% | -21.9% | -7.7% | +33.7% |
| Net MarginNet income ÷ Revenue | +10.5% | -20.7% | -10.8% | +29.4% |
| FCF MarginFCF ÷ Revenue | +23.6% | +18.1% | +19.0% | +42.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +26.0% | +26.9% | +18.5% | +9.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.6% | 0.0% | +83.2% | +10.1% |
Valuation Metrics
QLYS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 17.5x trailing earnings, QLYS trades at a 75% valuation discount to AVPT's 68.8x P/E. On an enterprise value basis, QLYS's 13.5x EV/EBITDA is more attractive than CYBR's 908.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.2B | $3.4B | $20.6B | $3.3B |
| Enterprise ValueMkt cap + debt − cash | $1.8B | $3.7B | $21.2B | $3.2B |
| Trailing P/EPrice ÷ TTM EPS | 68.80x | -25.38x | -139.54x | 17.45x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.75x | 242.23x | 81.87x | 12.87x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 44.79x | — | 908.21x | 13.49x |
| Price / SalesMarket cap ÷ Revenue | 5.31x | 5.40x | 15.16x | 5.00x |
| Price / BookPrice ÷ Book value/share | 4.94x | 6.19x | 8.54x | 6.17x |
| Price / FCFMarket cap ÷ FCF | 27.32x | 24.99x | 79.60x | 10.98x |
Profitability & Efficiency
AVPT leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
QLYS delivers a 37.2% return on equity — every $100 of shareholder capital generates $37 in annual profit, vs $-27 for VRNS. AVPT carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRNS's 0.96x. On the Piotroski fundamental quality scale (0–9), AVPT scores 6/9 vs CYBR's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.2% | -27.4% | -6.1% | +37.2% |
| ROA (TTM)Return on assets | +6.3% | -8.2% | -3.0% | +19.1% |
| ROICReturn on invested capital | +11.4% | -11.0% | -3.2% | +47.5% |
| ROCEReturn on capital employed | +8.1% | -14.0% | -3.3% | +37.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.02x | 0.96x | 0.51x | 0.17x |
| Net DebtTotal debt minus cash | -$471M | $369M | $599M | -$153M |
| Cash & Equiv.Liquid assets | $481M | $202M | $623M | $250M |
| Total DebtShort + long-term debt | $10M | $572M | $1.2B | $97M |
| Interest CoverageEBIT ÷ Interest expense | — | -9.01x | — | — |
Total Returns (Dividends Reinvested)
CYBR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CYBR five years ago would be worth $34,006 today (with dividends reinvested), compared to $6,014 for VRNS. Over the past 12 months, CYBR leads with a +13.3% total return vs AVPT's -40.0%. The 3-year compound annual growth rate (CAGR) favors CYBR at 43.4% vs QLYS's -6.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -21.9% | -10.5% | -6.1% | -27.5% |
| 1-Year ReturnPast 12 months | -40.0% | -36.7% | +13.3% | -25.6% |
| 3-Year ReturnCumulative with dividends | +133.0% | +23.7% | +194.8% | -17.7% |
| 5-Year ReturnCumulative with dividends | +1.7% | -39.9% | +240.1% | -3.1% |
| 10-Year ReturnCumulative with dividends | +5.5% | +317.5% | +901.8% | +267.2% |
| CAGR (3Y)Annualised 3-year return | +32.6% | +7.3% | +43.4% | -6.3% |
Risk & Volatility
Evenly matched — CYBR and QLYS each lead in 1 of 2 comparable metrics.
Risk & Volatility
QLYS is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than AVPT's 1.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CYBR currently trades 77.7% from its 52-week high vs VRNS's 44.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.06x | 0.95x | 0.92x | 0.53x |
| 52-Week HighHighest price in past year | $20.25 | $63.90 | $526.19 | $155.47 |
| 52-Week LowLowest price in past year | $8.83 | $19.70 | $347.12 | $74.51 |
| % of 52W HighCurrent price vs 52-week peak | +51.0% | +44.9% | +77.7% | +61.1% |
| RSI (14)Momentum oscillator 0–100 | 54.1 | 66.1 | 38.9 | 54.2 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 2.3M | 0 | 773K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: AVPT as "Buy", VRNS as "Buy", CYBR as "Buy", QLYS as "Hold". Consensus price targets imply 69.6% upside for AVPT (target: $18) vs 12.3% for CYBR (target: $459).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $17.50 | $36.00 | $459.00 | $134.30 |
| # AnalystsCovering analysts | 12 | 34 | 49 | 48 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.2% | +3.4% | +0.0% | +5.5% |
QLYS leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). AVPT leads in 1 (Profitability & Efficiency). 1 tied.
AVPT vs VRNS vs CYBR vs QLYS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AVPT or VRNS or CYBR or QLYS a better buy right now?
For growth investors, CyberArk Software Ltd.
(CYBR) is the stronger pick with 36. 0% revenue growth year-over-year, versus 10. 1% for Qualys, Inc. (QLYS). Qualys, Inc. (QLYS) offers the better valuation at 17. 5x trailing P/E (12. 9x forward), making it the more compelling value choice. Analysts rate AvePoint, Inc. (AVPT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVPT or VRNS or CYBR or QLYS?
On trailing P/E, Qualys, Inc.
(QLYS) is the cheapest at 17. 5x versus AvePoint, Inc. at 68. 8x. On forward P/E, Qualys, Inc. is actually cheaper at 12. 9x.
03Which is the better long-term investment — AVPT or VRNS or CYBR or QLYS?
Over the past 5 years, CyberArk Software Ltd.
(CYBR) delivered a total return of +240. 1%, compared to -39. 9% for Varonis Systems, Inc. (VRNS). Over 10 years, the gap is even starker: CYBR returned +901. 8% versus AVPT's +5. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVPT or VRNS or CYBR or QLYS?
By beta (market sensitivity over 5 years), Qualys, Inc.
(QLYS) is the lower-risk stock at 0. 53β versus AvePoint, Inc. 's 1. 06β — meaning AVPT is approximately 100% more volatile than QLYS relative to the S&P 500. On balance sheet safety, AvePoint, Inc. (AVPT) carries a lower debt/equity ratio of 2% versus 96% for Varonis Systems, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AVPT or VRNS or CYBR or QLYS?
By revenue growth (latest reported year), CyberArk Software Ltd.
(CYBR) is pulling ahead at 36. 0% versus 10. 1% for Qualys, Inc. (QLYS). On earnings-per-share growth, the picture is similar: AvePoint, Inc. grew EPS 193. 8% year-over-year, compared to -38. 2% for CyberArk Software Ltd.. Over a 3-year CAGR, CYBR leads at 32. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVPT or VRNS or CYBR or QLYS?
Qualys, Inc.
(QLYS) is the more profitable company, earning 29. 6% net margin versus -20. 7% for Varonis Systems, Inc. — meaning it keeps 29. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: QLYS leads at 33. 2% versus -23. 5% for VRNS. At the gross margin level — before operating expenses — QLYS leads at 82. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVPT or VRNS or CYBR or QLYS more undervalued right now?
On forward earnings alone, Qualys, Inc.
(QLYS) trades at 12. 9x forward P/E versus 242. 2x for Varonis Systems, Inc. — 229. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVPT: 69. 6% to $17. 50.
08Which pays a better dividend — AVPT or VRNS or CYBR or QLYS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is AVPT or VRNS or CYBR or QLYS better for a retirement portfolio?
For long-horizon retirement investors, CyberArk Software Ltd.
(CYBR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 92), +901. 8% 10Y return). Both have compounded well over 10 years (CYBR: +901. 8%, AVPT: +5. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVPT and VRNS and CYBR and QLYS?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AVPT is a small-cap high-growth stock; VRNS is a small-cap quality compounder stock; CYBR is a mid-cap high-growth stock; QLYS is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.